Share this link via:
The Mass Spectrometer Market size was USD 6.88 billion in 2022. Covid-19's pandemic has highlighted the importance of advanced analytical techniques and diagnostic tools in managing public health crises. This increased awareness and focus on healthcare preparedness and research are expected to create future opportunities for the mass spectrometer market as investments in healthcare infrastructure and research capabilities are likely to increase. Between 2023 and 2031, the market is projected to grow at a CAGR of 5%, from USD 7.43 billion in 2023 to USD 11.75 billion in 2031. The sudden rise in CAGR is attributed to this market growth returning to the pre-pandemic level once the pandemic is over according to a new report by Intellectual Market Insights Research.
The mass spectrometer market refers to the global market for instruments that are used to measure and analyze the masses and chemical compositions of molecules. A mass spectrometer is a scientific instrument that ionizes chemical compounds and separates the ions based on their mass-to-charge ratio. It is widely used in various industries and research fields for applications such as drug discovery, environmental analysis, food safety testing, clinical diagnostics, and forensic analysis. Mass spectrometers operate based on principles of ionization, mass analysis, and ion detection.
The scope of the mass spectrometer market encompasses the various aspects related to the production, distribution, and use of mass spectrometry instruments and related services. The scope also includes analysing market trends, growth drivers, and challenges that impact the adoption and expansion of mass spectrometry technologies. Mass spectrometry (MS) is an analytical chemistry technique that is widely used to identify and quantify chemical species in a sample. It measures the mass-to-charge ratio (m/z) and abundance of gas-phase ions generated from the sample. This includes factors such as technological advancements, increasing demand for advanced analytical tools, growing focus on personalized medicine, and the need for accurate and sensitive analysis in various industries. Several key players in the market are adopting strategies such as mergers, acquisition, partnerships, and collaboration for the expansion their product portfolio. For instance,
The pharmaceutical and biotechnology industries are indeed major driving factors for the growth of the mass spectrometer market. The high demand and resulting requirements from these industries contribute significantly to the adoption and advancement of mass spectrometry technology.
The high demand for drug discovery, quality control, biomarker research, and bioanalytical studies in the pharmaceutical and biotechnology industries are driving the adoption and growth of mass spectrometers. The continuous need for advanced analytical techniques to support these industries' research and development efforts further fuels the demand for mass spectrometry technology.
The growing demand for drug discovery and development is a significant driver for the adoption of mass spectrometry in the pharmaceutical and biotechnology industries.
Mass spectrometry facilitates the identification and validation of biomarkers, which are measurable indicators of biological processes or disease conditions. By analysing the metabolites, proteins, peptides, and other molecular entities in biological samples, mass spectrometry enables the discovery and verification of potential biomarkers for disease diagnosis, prognosis, and therapeutic response monitoring.
The Human Proteome Organization's Human Proteome Project (HPP) plays a crucial role in advancing the field of proteomics and mass spectrometry. In 2020, the HPP released updated guidelines on the data interpretation of mass spectrometry, specifically focusing on data-independent acquisition (DIA) workflows and the Universal Spectrum Identifier (USI) system.
The triple quadrupole (tandem) mass spectrometry is expected to hold a significant market share among the types of hybrid mass spectrometry. Triple quadrupole mass spectrometry is a widely used technique in various applications, including pharmaceutical analysis, clinical research, environmental analysis, and food safety testing.
Triple quadrupole mass spectrometry systems are known for their high speed and throughput capabilities. They can rapidly switch between different precursor-product ion pairs, allowing for efficient analysis of multiple analytes in a single run. This enhances productivity and reduces analysis time, making it suitable for large-scale screening applications.
The high specificity and sensitivity of LC-MS/MS overcome many limitations associated with the traditional immunoassays, such as non-specific antibody binding and cross reactivity.
Mass spectrometry is highly effective for the analysis of volatile and small to medium-sized molecules. However, it may have limitations in analysing non-volatile or high molecular weight compounds, such as polymers or large proteins. These compounds may require additional sample preparation or specialized techniques, which can add complexity and time to the analysis.
Mass spectrometers are complex and sophisticated instruments that require advanced technology and precision engineering. As a result, they tend to be expensive, making them less accessible to smaller laboratories or organizations with budget constraints. The high cost of mass spectrometers can hinder their widespread adoption, particularly in resource-limited settings.
The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2023-2031 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Based on the technology the market is segmented into Gas Chromatography, Liquid Chromatography, Matrix-Assisted Laser Desorption, Time-of-Flight Mass Spectrometry (TOF MS), Quadrupole Mass Spectrometry, Ion Trap Mass Spectrometry, Hybrid mass spectrometry and Others.
Hybrid mass spectrometry: Hybrid mass spectroscopy segment dominates the global market and is anticipated to continue this trend during the forecast period. the growth of this segment is attributable to higher sensitivity and lower limits of detection and higher resolving power.
Liquid Chromatography: Liquid Chromatography MS segment accounted for over 34% share of the global mass spectrometer in year 2021. Liquid chromatography (LC) is a widely used technique in the field of mass spectrometry (MS). When combined with MS, it forms the powerful analytical tool known as liquid chromatography-mass spectrometry (LC-MS). LC-MS combines the separation capabilities of liquid chromatography with the detection and identification capabilities of mass spectrometry.
Based on the application of the market is segmented into Life Science Research, Drug Discovery, Environmental Testing, Food Testing, Applied Industries, Clinical Diagnostics and Others.
Life Science: The life science research segment is expected to grow at the highest CAGR in the mass spectrometry market during the forecast period. the life science research segment dominated the market in 2022. The increasing application of omics technology in diagnostics & biomarker identification and the increasing R&D expenditure and government funding for proteomics are expected to drive the market for this segment.
Based on end user the market is segmented into Research and Academic Institutions, Pharmaceutical and Biotechnology, Contract Research Organizations (CROs), Hospitals and Clinical, Food and Beverage and Others.
Pharmaceutical and Biotechnology: The pharmaceutical and biotechnology companies segment played a dominant role in the mass spectrometer market in 2022, accounting for a significant share of 43.98%. This segment's dominance can be attributed to the extensive adoption of mass spectrometry in protein sequencing for drug discovery and development processes in the pharmaceutical industry.
In the pharmaceutical industry, protein sequencing using mass spectrometry is utilized in various applications, including target identification, validation, and lead optimization. Mass spectrometry allows researchers to analyze proteins and peptides with high sensitivity and accuracy, facilitating the understanding of protein structures, functions, and interactions.
By employing mass spectrometry for protein sequencing, pharmaceutical and biotechnology companies can gain insights into the biological processes associated with diseases, discover potential therapeutic targets, and evaluate the efficacy and safety of drug candidates. This drives the extensive adoption of mass spectrometry in the pharmaceutical industry, leading to the dominant market share of the pharmaceutical and biotechnology companies segment in 2022.
Study Period | 2020-31 |
Base Year | 2022 |
Estimated Forecast Year | 2023-31 |
Growth Rate | CAGR of 5% from 2023 to 2031 |
Segmentation | By Technology, By Application, By End User, By Region |
Unit | USD Billion |
By Technology |
|
By Application |
|
By End User |
|
By Region |
|
The North American market is expected to hold the largest share of this market during the forecast period. The high level of research and development (R&D) spending in the United States reflects the country's commitment to innovation and technological advancements. The substantial investment in R&D is crucial for driving scientific discoveries, technological breakthroughs, and economic growth. It enables the development of new products, processes, and services, and contributes to the competitiveness of industries.
According to the Industrial Research Institute (IRI) report, the United States spends the world’s highest (USD 516 billion) amount for research and development.
Investing 43% of the total life sciences/healthcare R&D spending and 56% of pharmaceutical/biotech R&D spending worldwide highlights the United States' leadership in these critical sectors. The country has a robust ecosystem of pharmaceutical and biotech companies, academic research institutions.
Europe plays a significant role in the global market, including the field of research and development (R&D). The region's substantial market size of around 2 billion USD in 2019, which is projected to reach 3 billion USD by 2027 with a compound annual growth rate (CAGR) of 7.2%, demonstrates its importance and growth potential.
Mass Spectrometer Market Report is also available for below Regions and Country Please Ask for that
You'll get the sample you asked for by email. Remember to check your spam folder as well. If you have any further questions or require additional assistance, feel free to let us know via-
+1 724 648 0810 +91 976 407 9503 sales@intellectualmarketinsights.com
20 Jun 2022